170
Views
4
CrossRef citations to date
0
Altmetric
Review

Developing precision treatments for epilepsy using patient and animal models

&
Pages 1241-1250 | Received 14 Sep 2020, Accepted 17 Dec 2020, Published online: 29 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Barbara Miziak & Stanisław J Czuczwar. (2022) Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy. Expert Opinion on Drug Discovery 17:12, pages 1313-1328.
Read now

Articles from other publishers (3)

Qun-Zheng Zhang, Zhi-Qiang Ouyang, Yu-Hao Zhou, Si-Chang Wang, Cong-Yu Ke, Ya-Jun Bai, Xun-Li Zhang & Xiao-Hui Zheng. (2023) Pilot-Scale Synthesis and Purification of α-Asaronol for Antiepileptic Drug Development. Organic Process Research & Development 27:7, pages 1308-1316.
Crossref
Qun-Zheng Zhang, Zhen-Hua Zhong, Ding Hao, Ming-Nan Feng, Si-Chang Wang, Qi-Long Han, Yajun Bai, Danni Xu, Sha Liao, Chaoni Xiao, Xun-Li Zhang & Xiaohui Zheng. (2022) Synthesis, crystal structure and bioactivities of α-asaronol. Acta Crystallographica Section C Structural Chemistry 78:5, pages 265-270.
Crossref
Marek J. Pawlik, Barbara Miziak, Aleksandra Walczak, Agnieszka Konarzewska, Magdalena Chrościńska-Krawczyk, Jan Albrecht & Stanisław J. Czuczwar. (2021) Selected Molecular Targets for Antiepileptogenesis. International Journal of Molecular Sciences 22:18, pages 9737.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.